The variation in gene expression profiles between IDH-mutant astrocytomas and oligodendrogliomas is primarily influenced by the tumor microenvironment and specific genetic mutations, rather than by distinct glial lineages. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).